Target intelligence / Profile preview

Fungal cell wall integrity pathway (CWI pathway)

Target
CWI pathway
Molecular classification
Signaling pathway, Kinase cascade (MAPK pathway), Enzyme (e.g., β-1,3-glucan synthase, chitin synthase)
01

Overview

The fungal cell wall integrity (CWI) pathway is a conserved signaling cascade in fungi that regulates the synthesis and remodeling of the cell wall in response to environmental stresses, antifungal drugs, and morphogenesis. At the core of this pathway is a MAPK cascade initiated by extracellular stress sensors, which signal through GTPases and kinases (notably protein kinase C, Pkc1) to downstream MAPK modules (such as Bck1-Mkk1/2-Slt2 in yeast), regulating the expression of enzymes responsible for wall biosynthesis (e.g., β-1,3-glucan synthase, chitin synthase) and morphogenetic factors. Disruption of this signaling impairs fungal survival, makes the cell wall vulnerable, and underpins the mechanism of action of major antifungal drugs (like echinocandins). As the cell wall is essential and absent in host animals, the pathway and its molecular components are primary antifungal targets, though its complexity and compensatory signaling can lead to therapeutic resistance[1][3][4][6][9].\n\nIn summary, "Fungal cell wall integrity" is a process and signaling pathway, not a single druggable receptor or protein, though its molecular constituents (e.g., β-1,3-glucan synthase, pathway kinases) are proven, specific antifungal drug targets.

Other names
Cell wall integrity pathwayCWI pathwayfungal CWI pathway
02

Mechanism of action

Inhibition of β-1,3-glucan synthase (disrupts glucan synthesis, weakens wall, causes lysis)\nInhibition of GPI-anchor biosynthesis (hinders cell wall protein anchoring)\nDisruption of cell wall assembly and stress signaling cascade

03

Biological functions

Cell wall biosynthesisStress response signal transductionCell polarity and morphogenesisVirulence factor regulation
04

Disease associations

Infection (particularly invasive mycosis)Antifungal drug resistance
05

Safety considerations

Limited to fungal targets (absent in humans, thus low off-target toxicity)Resistance can arise via mutations or compensatory upregulation (especially chitin synthesis)Sometimes limited efficacy in immunocompromised patients with specific fungal species
06

Interacting drugs

Echinocandins (e.g., caspofungin, micafungin, anidulafungin)

2 more in the full profile.

07

Biomarkers

β-1,3-glucan (cell wall component, also used in clinical diagnostics)Chitin content (rises with echinocandin exposure)Molecular markers: FKS1/FKS2 gene mutations (echinocandin resistance)

Beyond the preview

Go deeper on Fungal cell wall integrity pathway (CWI pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal cell wall integrity pathway (CWI pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call